FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES
FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES
批准号:
2694646
负责人:
LEROY F LIU
金额:
$28.29万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-04-01 至 2002-06-30
关键词:
DNA damage DNA topoisomerases Drosophilidae Escherichia coli Saccharomyces cerevisiae alternatives to animals in research apoptosis bacterial genetics enzyme mechanism fungal genetics genetic promoter element hydrogen peroxide molecular cloning nucleic acid structure oxidative stress protein binding protein isoforms site directed mutagenesis thiols transcription factor yeast two hybrid system
中文摘要
我们的长期目标是了解分子机制和
多种DNA拓扑异构酶的生理功能。在当前
应用,我们建议研究这两种人类拓扑异构酶的作用
染色体环区组织中的II(TOP2)亚型与细胞凋亡
细胞死亡。已知许多TOP2靶向抗癌药物可诱导
细胞凋亡性死亡与高分子量DNA片段化
(约50kb)。这些HMW DNA片段可能反映了TOP2介导的
TOP2位于其上的染色体环域的切除
环状锚地。令人惊讶的是,类似的HMW DNA模式
在细胞凋亡中也观察到片段化(主要是50kb)。
由不同刺激诱导的细胞,其中许多已知诱导
氧化应激。HMW DNA的断裂被认为是一种
在细胞凋亡过程中迈出的重要一步,但这种酶
对HMW DNA碎裂负有责任的人尚未确定。我们的
初步研究表明,这两种人类DNA TOP2
TOP2a和TOP2b亚型可以被激活,成为DNA裂解
过氧化氢产生的一种活性氧物种(ROS)产生的“核酸酶”
在氧化应激过程中。氧化应激被认为是一种
过氧化氢对TOP2b(和/或TOP2A)的潜在细胞激活作用
在氧化应激过程中导致HMW DNA断裂
凋亡性细胞。当前有两个主要的具体目标
申请;(1)。人类TOP2亚型的功能研究。二
将采用鉴定TOP2相互作用蛋白的方法
产生显性负性突变型TOP2细胞系。除了……之外
检测TOP2亚型在中国人染色体环区突变中的作用
患有Bloom综合征(基因组不稳定)和WRN的患者发生突变
在沃纳综合征(早衰)患者中。(2)。至
建立人TOP2亚型在HMW DNA断裂中的作用
细胞凋亡性死亡我们将确定TOP2(以及TOP2的哪个亚型)
在用过氧化氢或过氧化氢处理的细胞中被激活为“核酸酶”
其他特工。我们还将确定哪种TOP2亚型负责
HMW DNA在凋亡细胞死亡过程中的断裂。
英文摘要
Our long-term objective is to understand the molecular mechanism and
physiological function of multiple DNA topoisomerases. In the current
application, we propose to study the roles of the two human topoisomerase
II (TOP2) isoforms in chromosomal loop domain organization and apoptotic
cell death. Many TOP2-targeted anti-cancer drugs are known to induce
apoptotic cell death and high molecular weight (HMW) DNA fragmentation
(about 50 kb). These HMW DNA fragments presumably reflect TOP2-mediated
excision of chromosomal loop domains in which TOP2 is located at their
loop anchorage sites. Strikingly, a similar pattern of HMW DNA
fragmentation (predominantly 50 kb) has also been observed in apoptotic
cells induced by diverse stimuli many of which are known to induce
oxidative stress. The HMW DNA fragmentation has been suggested to be a
committed step in the apoptotic cell death process, but the enzyme
responsible for HMW DNA fragmentation has not been identified. Our
preliminary studies have demonstrated that the two human DNA TOP2
isoforms, TOP2a and TOP2b, can be activated to become DNA cleaving
"nucleases" by hydrogen peroxide, a reactive oxygen species (ROS) produced
during oxidative stress. Oxidative stress has been suggested to be a
potential cellular activation of TOP2b (and/or TOP2a) by hydrogen peroxide
during oxidative stress is responsible for HMW DNA fragmentation in
apoptotic cells. There are two major specific aims for the current
application; (1). Functional studies of human TOP2 isoforms. Two
approaches will be employed, identification of TOP2-interacting proteins
and generating dominant negative mutant TOP2 cell lines. In addition to
testing the roles of TOP2 isoforms in chromosomal loop domains mutated in
patients with the Bloom's syndrome (genome instability) and WRN, mutated
in patients with the Werner's syndrome (premature aging). (2). To
establish the roles of human TOP2 isoforms in HMW DNA fragmentation during
apoptotic cell death. We will determine if TOP2 ( and which TOP2 isoform)
is activated into a "nuclease" in cells treated with hydrogen peroxide or
other agents. We will also determine which TOP2 isoform is responsible for
HMW DNA fragmentation during apoptotic cell death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training in Cancer Pharmacology
-
批准号:7128170
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:6894915
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7292666
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7498567
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7681012
-
项目类别:
-
资助金额:$12.94万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8129544
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7526710
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:7006957
-
项目类别:
-
资助金额:$28.02万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:6782758
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8307026
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7669433
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7869327
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:7194334
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:6868144
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8700947
-
项目类别:
-
资助金额:$6.58万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6687804
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES
-
批准号:6173399
-
项目类别:
-
资助金额:$22.6万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6621894
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6437280
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES
-
批准号:2896423
-
项目类别:
-
资助金额:$21.94万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
海外基金